Key Takeaways From The Global Cell And Gene Therapy Supply Chain Or Logistics Market Forecast 2023
The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032
As per The Business Research Company’s Cell And Gene Therapy Supply Chain Or Logistics Global Market Report 2023, the cell and gene therapy supply chain or logistics market is expected to show significant growth in the forecast period.
Key insights from the cell and gene therapy supply chain or logistics market forecast include:
- Market Size
The global cell and gene therapy supply chain or logistics market is expected to grow from $1.1 billion in 2022 to $1.25 billion in 2023 at a compound annual growth rate (CAGR) of 12.8%. The cell and gene therapy supply chain/logistics market is expected to reach $1.93 billion in 2027 at a CAGR of 11.5%.
- Major Driver
The increasing need for cell and gene therapies is driving the cell and gene therapy supply chain/logistics market. For instance, in February 2022, according to Cell & Gene, a US-based online resource for research scholars, the private investment in cell and gene therapy in 2021 was $68 billion, up from $362 million in 2020. Moreover, the number of approved cell and gene therapies experienced a 10% growth in 2021. Therefore, the increasing need for cell and gene therapies drives the cell and gene therapy supply chain/logistics market forward.
View More On The Cell And Gene Therapy Supply Chain Or Logistics Market Report 2023 – https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-supply-chain-or-logistics-global-market-report
- Key Trend
Modern technology platforms are a key trend gaining popularity in the cell and gene therapy supply chain/logistics markets. Major companies operating in the cell and gene therapy supply chain/logistics market are developing modern technology platforms for cell and gene therapies to sustain their position in the market. For instance, in April 2023, AmerisourceBergen Corporation., a US-based healthcare company specializing in cell and gene therapy supply chain logistics, launched the Cell and Gene Therapy (CGT) Integration Hub. The Cell and Gene Therapy (CGT) Integration Hub is powered by AmerisourceBergen’s innovative customer relationship management (CRM) system. It can be integrated into the biopharma platform to facilitate better monitoring of the development and delivery of cell and gene therapies.
- Largest Region
North America was the largest region in the cell and gene therapy supply chain/logistics market in 2022.
- Major Players
Major players in the cell and gene therapy supply chain/logistics market are AmerisourceBergen Corporation, United Parcel Service, Thermo Fisher Scientific Inc., Avantor Sciences, Lonza Group AG, Arvato Group, Catalent Inc., Charles River Laboratories International, Parexel International Corporation, Cytiva, Almac Group, World Courier, Sharp Packaging Services, PCI Pharma Services, Cryoport Inc., Brooks Life Sciences, BioLife Solutions Inc., Biocair Inc., QuickSTAT, Clarkston Consulting Inc., Central Pharma, TrakCel limited, MAK-SYSTEM International Group, Hypertrust Patient Data Care GmbH, Atelerix Ltd., Polar Express Transportation, Be The Match BioTherapies Inc., Yourway Biopharma Services Company, Azenta Life Sciences Inc., and Biostor Ltd.
Request A Sample Of The Global Cell And Gene Therapy Supply Chain Or Logistics Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=12631&type=smp
Key Cell And Gene Therapy Supply Chain Or Logistics Market Segments
The global cell and gene therapy supply chain or logistics market is segmented –
1) By Type Of Software Solution: Cell Orchestration Platform, Enterprise Manufacturing System, Inventory Management System, Laboratory Information Management System, Logistics Management System, Patient Management System, Quality Management System, Tracking And Tracing System
2) By Mode Of Deployment: Cloud-Based Solution, On-Premises Solution
3) By Component: Cryogenic Shippers, Cryogenic Storage Freezers, Ultra-Low Freezers, Cold Chain Management Systems, Shipment, Storage Medium, Cryogenic Packout Kits, Other Components
4) By Application Area: Donor Eligibility Assessment, Sample Collection, Manufacturing, Logistics, Patient Verification, Treatment Follow-Up
5) By End User: Biobank, Cell Therapy Lab, Hospital, Research Institute, Commercial Organization
The Cell And Gene Therapy Supply Chain Or Logistics Global Market Report 2023 provides an in-depth analysis on the cell and gene therapy supply chain or logistics market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the cell and gene therapy supply chain or logistics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
View More Related Reports –
Cell & Gene Therapy Manufacturing Services Global Market Report 2023
Gene Therapy Global Market Report 2023
Cell Based Assays Global Market Report 2023
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
